Occludin (Ocln) (C-Terminus) Antibody - Western Blot Validated

Scientific Overview

When control selection matters, this antibody helps you assess Occludin C-Terminus (Ocln) in a structured study. Occludin C-Terminus is a contact-site protein that shapes barrier properties and signaling at the cell surface. Plan positive and negative controls that match your model system, including perturbations expected to shift the target.

In some datasets and protocols, it is referenced by the gene symbol Ocln.

Research Relevance

In cultured models, junctional readouts can change rapidly after calcium modulation or cytoskeletal perturbation. Time course design can be decisive when regulation is transient or compartment dependent.

When cell-state transitions occur, this target may change alongside partners in the same compartment or pathway neighborhood.

When building a narrative around the target, it helps to track:

• changes in complex assembly with scaffold or adaptor proteins
• co-localization patterns with cytoskeletal elements
• subcellular redistribution at contact sites versus cytoplasm

Application-Specific Context

When samples are prepared in reducing conditions, some epitopes become more accessible; this version is designed with that context in mind. Think about how preparation affects epitope accessibility, and interpret patterns alongside morphology and compartment markers as needed. Align controls to the expected direction of change to support confident interpretation.

For challenging targets, pairing Occludin C-Terminus measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

Use the denaturing-format option to keep Occludin C-Terminus (Ocln) analysis aligned with planned contrasts and endpoints.